IKT – inhibikase therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High	4.92 03/15/24
52 Week Low	0.79 03/15/24


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

IKT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/25

04:10 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher

Report

2/25

04:10 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent

Report

2/25

04:06 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Iwicki Mark T

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Iwicki Mark T

Report

2/25

04:05 pm

ikt

Form 3 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher

Medium Report

Form 3 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher

Report

2/25

04:05 pm

ikt

Form 3 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent

Medium Report

Form 3 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent

Report

2/24

08:14 am

ikt

Form 8-K Inhibikase Therapeutics, For: Feb 21

High Report

Form 8-K Inhibikase Therapeutics, For: Feb 21

Report

2/19

08:26 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Iwicki Mark T

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Iwicki Mark T

Report

2/19

08:24 pm

ikt

Form 3 Inhibikase Therapeutics, For: Feb 14 Filed by: Iwicki Mark T

Medium Report

Form 3 Inhibikase Therapeutics, For: Feb 14 Filed by: Iwicki Mark T

Report

2/19

08:19 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Bellini Roberto

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Bellini Roberto

Report

2/19

08:19 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Kush Arvind

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Kush Arvind

Report

2/19

08:17 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Freeman Roy Lester

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Freeman Roy Lester

Report

2/19

08:12 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Munshi Amit

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Munshi Amit

Report

2/19

08:11 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Canner David

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: Canner David

Report

2/19

08:07 pm

ikt

Form 4/A Inhibikase Therapeutics, For: Jan 21 Filed by: BERMAN DENNIS N

Medium Report

Form 4/A Inhibikase Therapeutics, For: Jan 21 Filed by: BERMAN DENNIS N

Report

2/19

08:01 pm

ikt

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: BERMAN DENNIS N

Medium Report

Form 4 Inhibikase Therapeutics, For: Feb 14 Filed by: BERMAN DENNIS N

Report

2/18

08:10 am

ikt

Form 8-K Inhibikase Therapeutics, For: Feb 13

Low Report

Form 8-K Inhibikase Therapeutics, For: Feb 13

Report

2/14

09:05 pm

ikt

Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: ADAR1 Capital Management, LLC

Medium Report

Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: ADAR1 Capital Management, LLC

Report

2/14

05:36 pm

ikt

Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: ARMISTICE CAPITAL, LLC

Low Report

Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: ARMISTICE CAPITAL, LLC

Report

2/14

04:36 pm

ikt

Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: Nantahala Capital Management, LLC

Medium Report

Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: Nantahala Capital Management, LLC

Report

2/14

04:09 pm

ikt

Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Point72 Asset Management, L.P.

High Report

Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Point72 Asset Management, L.P.

Report

2/14

03:45 pm

ikt

Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Fairmount Funds Management LLC

Low Report

Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Fairmount Funds Management LLC

Report

2/4

04:07 pm

ikt

Form S-8 Inhibikase Therapeutics,

Low Report

Form S-8 Inhibikase Therapeutics,

Report

1/29

04:05 pm

ikt

Form 8-K Inhibikase Therapeutics, For: Jan 29

High Report

Form 8-K Inhibikase Therapeutics, For: Jan 29

Report

1/22

04:05 pm

ikt

Form 4 Inhibikase Therapeutics, For: Jan 21 Filed by: Freeman Roy Lester

Low Report

Form 4 Inhibikase Therapeutics, For: Jan 21 Filed by: Freeman Roy Lester

Report

1/22

04:05 pm

ikt

Form 4 Inhibikase Therapeutics, For: Jan 21 Filed by: Werner Milton H.

Low Report

Form 4 Inhibikase Therapeutics, For: Jan 21 Filed by: Werner Milton H.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.